"La Polyclinique du Parc est un établissement de santé pluridisciplinaire situé à Cholet, en Pays de la Loire. Elle fait partie du Groupe Vivalto Santé, troisième acteur national de l'hospitalisation privée."

During the past decade, Polyclinique du Parc conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Polyclinique du Parc" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Polyclinique du Parc" are "Prostate Cancer" (2 trials) and "Bradycardia" (1 trials). Many other conditions were trialed in "Polyclinique du Parc" in a lesser frequency.

Most popular intervention types in "Polyclinique du Parc" are "Drug" (2 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "docetaxel" (2 trials), "Estramustine phosphate sodium" (1 trials), "Goserelin Acetate" (1 trials), "acetylsalicylic acid" (1 trials) and "antiandrogen therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Polyclinique du Parc" are 2 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Polyclinique du Parc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Polyclinique du Parc, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Polyclinique du Parc, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".